✦ LIBER ✦

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin

✍ Scribed by U. Graefe-Mody; C. Friedrich; A. Port; A. Ring; S. Retlich; T. Heise; A. Halabi; H.-J. Woerle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The influence of hepatic impairment on t

✍ Y.-L. He; R. Sabo; J. Campestrini; Y. Wang; M. Ligueros-Saylan; K. C. Lasseter; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 240 KB

Pharmacokinetics, pharmacodynamics and t

✍ T. Heise; E. U. Graefe-Mody; S. Hüttner; A. Ring; D. Trommeshauser; K. A. Dugi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB

Effect of renal impairment on the pharma

✍ Helle Linnebjerg; Prajakti A. Kothare; Soomin Park; Kenneth Mace; Shobha Reddy; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 320 KB

Effect of renal impairment on the pharma

✍ Massarella, Joseph W; Khoo, Ko-Chin; Aogaichi, Keiko; Di Persio, David; Smith, M 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 439 KB

Mechanisms of action of the dipeptidyl p

✍ B. Ahrén; A. Schweizer; S. Dejager; E. B. Villhauer; B. E. Dunning; J. E. Foley 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 870 KB

Sitagliptin, an dipeptidyl peptidase-4 i

✍ Goutam C. Mistry; Arthur J. Bergman; Wei Zheng; David Hreniuk; Miguel A. Zinny; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB